Sign in
WithdrawnNo phase

Understanding the Impact of Drug Shortages on Oncology Care Delivery

Key facts

Who runs it
University of Rochester NCORP Research Base
Where
Minneapolis, Robbinsdale, Saint Paul, Spartanburg, and Winston-Salem, United StatesSee the 6 sites
Trial code
Status
Withdrawn
Started
1 Jul 2018
Ended
18 Jun 2025
Type of study
Observational
Treatments tested
  • Survey Administration
Record updated
4 April 2025
Why it stopped
Study is not human subjects research.

Who can take part

Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Be a primary affiliate or sub-affiliate of an NCORP community site or minority underserved (M/U) community site that is affiliated with the University of Rochester Cancer Center (URCC) NCORP Research Base; Practice sites must have a valid Cancer Therapy Evaluation Program (CTEP) identification number; Practice sites may or may not share a pharmacy
  • Provide infusional chemotherapy treatment (either inpatient or outpatient)

Who cannot take part

  • Practice sites that do not provide infusional chemotherapy
  • Practices sites without valid CTEP identification (ID)

Where in United States

  • Health Partners IncMinneapolis, United States
  • Hennepin County Medical CenterMinneapolis, United States
  • North Memorial Medical Health CenterRobbinsdale, United States
  • Regions HospitalSaint Paul, United States
  • Spartanburg Medical CenterSpartanburg, United States
  • Southeast Clinical Oncology Research ProgramWinston-Salem, United States

About the trial

What the trial wants to find out

This trial studies the impact of drug shortages on oncology care delivery. Gathering information about cancer drug shortages over time may help researchers improve access to drugs during times of shortages.

The group in the trial

  • Health Services Research (surveys about drug shortages)

    At baseline, practice sites complete a Baseline Drug Shortage Survey and Pharmacy Baseline Survey; Drug Shortage Incident Reports are completed in real time as cancer care delivery problems occur; and the Quarterly Follow-Up Survey Number Treated Report every 3 months for one year (4 total).

    Treatment: Survey Administration

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
4 April 2025